Efficacy of Japanese traditional (Kampo) medicine for treating chemotherapy-induced peripheral neuropathy: A retrospective case series study

Table 1 Patient demographic characteristics

		n (%)
Sex	Male	6 (25.0)
	Female	18 (75.0)
Age	Mean (range)	61.2 ± 11.5 (39-86)
Primary tumor	Breast	11 (45.8)
	Gynecological	4 (16.7)
	Hematological	3 (12.5)
	Gastrointestinal	3 (12.5)
	Others	3 (12.5)
Responsible chemotherapeutic agents (overlapping, see Table 4)	Taxanes	15 (62.5)
	Platinum analogues	7 (29.2)
	Vinca alkaloids	3 (12.5)
	Bortezomiib	3 (12.5)
Duration until starting Kampo medicine after responsible chemotherapy	During chemotherapy	6 (25.0)
	< 6 mo after	8 (33.3)
	7-12 mo after	4 (16.7)
	> 13 mo after	6 (25.0)